Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

RCUSRCUS
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in Arcus Biosciences, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 941,756 shares of RCUS (Arcus Biosciences, Inc.), worth $29M as of 2026-Q2. The position was increased (+4.2% shares). RCUS represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$29M

Current Shares

941,756

Total Value Change

+$20.4M

Total Shares Change

+374,777

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
941,756
+4.2%
$29M0.0%$30.83
30
2026-Q1
Decreased
903,638
-6.7%
$19.5M0.0%$22.43
0
2025-Q4
Increased
968,241
+11.2%
$23.1M0.0%$23.23
32
2025-Q3
Increased
871,150
+12.2%
$11.8M0.0%$13.32
31
2025-Q2
Increased
776,742
+8.8%
$6.3M0.0%$7.95
30
2025-Q1
Increased
714,002
+23.2%
$5.6M0.0%$8.17
33
2024-Q4
Increased
579,623
+2.2%
$8.6M0.0%$14.91
28
2024-Q3
Increased
566,979
+11.7%
$8.7M0.0%$15.41
31

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used